Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cixutumumab and Temsirolimus in Metastatic Breast Cancer
NCT00699491Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2008
- Primary completion
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cixutumumab in breast cancer, sponsored by National Cancer Institute. Started Oct 2008; status: completed.
02
Drugs
cixutumumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00699491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699491.